Evidence map›Paper›PMID 27834681›Full record

ArticleThe Journal of biological chemistry2016

Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.

Hao Hu, Cheng Luo, Y George Zheng

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Structure, Activity, and Function of PRMT1.Life (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Mechanisms and Inhibitors of Histone Arginine Methylation.Chemical record (New York, N.Y.) · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Hao HuFrom the Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia 30602 and.
Cheng Luothe State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Y George ZhengFrom the Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia 30602 and yzheng@uga.edu.
University of Georgia · USShanghai Institute of Materia Medica · CN

Funding

Chemical Approaches to Protein Arginine MethylationR01GM086717 · NIGMS · UNIVERSITY OF GEORGIA · PI ZHENG, Y. GEORGE · 2010 to 2014
$1.2M
NIGMS NIH HHS R01 GM086717
6 · The paper itself

Abstract

Protein arginine methyltransferases (PRMTs) are the enzymes responsible for posttranslational methylation of protein arginine residues in eukaryotic cells, particularly within the histone tails. A detailed mechanistic model of PRMT-catalyzed methylation is currently lacking, but it is essential for understanding the functions of PRMTs in various cellular pathways and for efficient design of PRMT inhibitors as potential treatments for a range of human diseases. In this work, we used stopped-flow fluorescence in combination with global kinetic simulation to dissect the transient kinetics of PRMT1, the predominant type I arginine methyltransferase. Several important mechanistic insights were revealed. The cofactor and the peptide substrate bound to PRMT1 in a random manner and then followed a kinetically preferred pathway to generate the catalytic enzyme-cofactor-substrate ternary complex. Product release proceeded in an ordered fashion, with peptide dissociation followed by release of the byproduct S-adenosylhomocysteine. Importantly, the dissociation rate of the monomethylated intermediate from the ternary complex was much faster than the methyl transfer. Such a result provided direct evidence for distributive arginine dimethylation, which means the monomethylated substrate has to be released to solution and rebind with PRMT1 before it undergoes further methylation. In addition, cofactor binding involved a conformational transition, likely an open-to-closed conversion of the active site pocket. Further, the histone H4 peptide bound to the two active sites of the PRMT1 homodimer with differential affinities, suggesting a negative cooperativity mechanism of substrate binding. These findings provide a new mechanistic understanding of how PRMTs interact with their substrates and transfer methyl groups.

Indexed as

ArginineCatalysisCrystallography, X-RayHistonesHumansKineticsMethylationModels, MolecularMutagenesis, Site-DirectedMutant ProteinsMutationPeptide FragmentsProtein-Arginine N-MethyltransferasesProtein ConformationRepressor ProteinsS-AdenosylhomocysteineArginineHistonesMutant ProteinsPeptide FragmentsPRMT1 protein, humanProtein-Arginine N-MethyltransferasesRepressor ProteinsS-Adenosylhomocysteineenzyme catalysishistone methylationordered and random binding mechanismpre-steady-state kineticsPRMTprocessivityprotein methylationstopped-flowtransient kinetics

Identifiers

PMID27834681
PMCPMC5207181
OpenAlexW2555282473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.